All the information you need about CONFRATERNELLE D EXPLOITATION ET DE REPARTITION PHARMACEUTIQ to develop and secure your business in France

| Deposit | Confidentiality | closing date | document |
|---|---|---|---|
| 2022-08-03 | Public | 2021-12-31 | Complete |
| 2021-09-30 | Public | 2020-12-31 | Consolidated |
| 2020-07-29 | Public | 2019-12-31 | Simplified |
| 2019-07-15 | Public | 2018-12-31 | Consolidated |
| 2018-08-08 | Public | 2017-12-31 | Consolidated |
| 2018-07-10 | Public | 2017-12-31 | Complete |
| 2017-07-20 | Public | 2016-12-31 | Complete |
| Name | CONFRATERNELLE D EXPLOITATION ET DE REPARTITION PHARMACEUTIQ |
| Siren | 535420533 |
| Closing | 2017-12-31 |
| Registry code | 9001 |
| Registration number | 2751 |
| Management number | 1954B00053 |
| Activity code | 4646Z |
| Closing date n-1 | 2016-12-31 |
| Duration Fiscal year | 12 |
| Duration Fiscal year n-1 | 00 |
| Filing date | 2018-08-08 |
| Modification | 01 Annual accounts entered with accounting inconsistencies at document source |
| Balance sheet type | K : Consolidated |
| Currency code | EUR |
| Confidentiality | Public |
| Address | 90000 Belfort |
| 1 - Assets (balance sheet) | Gross amount N | Amortization year N | Net year N | Net year N-1 |
AJ Other Intangible Assets | 3 157 641.00 | |||
BJ TOTAL (I) | 70 024 681.00 | |||
BX Customers and related accounts | 184 805 445.00 | |||
CF Cash and cash equivalents | 147 468 898.00 | |||
CJ TOTAL (II) | 469 756 089.00 | |||
CO Grand total (0 to V) | 541 478 561.00 | |||
| 2 - Liabilities (balance sheet) | Amount year N | Amount year N-1 | ||
DA Share or individual capital | 23 289 000.00 | 23 289 000.00 | 23 289 000.00 | |
DL TOTAL (I) | 236 571 618.00 | 227 430 094.00 | 236 571 618.00 | |
DR TOTAL (IV) | 11 926 933.00 | 13 919 108.00 | 11 926 933.00 | |
DV Miscellaneous Loans and Financial Debts (4) | 29 578 937.00 | 27 974 295.00 | 29 578 937.00 | |
DW Advances and down payments received on current orders | 6 445 594.00 | 6 649 310.00 | 6 445 594.00 | |
DX Trade payables and related accounts | 225 331 134.00 | 233 328 377.00 | 225 331 134.00 | |
DY Tax and social security liabilities | 23 424 745.00 | 22 468 084.00 | 23 424 745.00 | |
EE Grand total (I to V) | 541 478 561.00 | 539 337 352.00 | 541 478 561.00 | |
| 3 - Income statement | Amount France year N | Amount Export year N | Total year N | Total year N-1 |
FJ Net sales | 2 034 101 022.00 | |||
FW Other purchases and external expenses | -29 116 566.00 | |||
FX Taxes, duties, and similar payments | -30 968 879.00 | |||
GB Operating Expenses - Provisions | -11 722 409.00 | |||
GG - OPERATING RESULT (I - II) | 12 214 507.00 | |||
GP Total financial income (V) | 4 712 070.00 | |||
GU Total financial expenses (VI) | -4 906 282.00 | |||
GV - FINANCIAL INCOME (V - VI) | -194 212.00 | |||
| 4 - Income statement (continued) | Amount year N | Amount year N-1 | ||
HD Total exceptional income (VII) | 1 689 784.00 | 633 308.00 | 1 689 784.00 | |
HH Total exceptional expenses (VIII) | -2 188 313.00 | -565 051.00 | -2 188 313.00 | |
HI - EXCEPTIONAL RESULT (VII - VIII) | -498 529.00 | 68 257.00 | -498 529.00 | |
HK Income tax | -5 275 982.00 | -5 721 148.00 | -5 275 982.00 | |
R5 Net income of consolidated companies | 6 603 598.00 | 11 404 070.00 | 6 603 598.00 | |
R6 Group Income (Consolidated Net Income) | 9 008 846.00 | 11 423 986.00 | 9 008 846.00 | |
